Suppr超能文献

肝内胆管癌的管理

Management of Intrahepatic Cholangiocarcinoma.

作者信息

Kodali Sudha, Shetty Akshay, Shekhar Soumya, Victor David W, Ghobrial Rafik M

机构信息

Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston, TX 77030, USA.

Houston Methodist Research Institute, Houston, TX 77030, USA.

出版信息

J Clin Med. 2021 May 27;10(11):2368. doi: 10.3390/jcm10112368.

Abstract

Cholangiocarcinoma is a tumor that arises as a result of differentiation of the cholangiocytes and can develop from anywhere in the biliary tree. Subtypes of cholangiocarcinoma are differentiated based on their location in the biliary tree. If diagnosed early these can be resected, but most cases of intrahepatic cholangiocarcinoma present late in the disease course where surgical resection is not an option. In these patients who are poor candidates for resection, a combination of chemotherapy, locoregional therapies like ablation, transarterial chemo and radioembolization, and in very advanced and metastatic disease, external radiation are the available options. These modalities can improve overall disease-free and progression-free survival chances. In this review, we will discuss the risk factors and clinical presentation of intrahepatic cholangiocarcinoma, diagnosis, available therapeutic options, and future directions for management options.

摘要

胆管癌是一种由胆管细胞分化产生的肿瘤,可发生于胆道树的任何部位。胆管癌的亚型根据其在胆道树中的位置进行区分。如果早期诊断,这些肿瘤可以切除,但大多数肝内胆管癌病例在疾病进程晚期才出现,此时手术切除并非可行选择。对于这些不适合手术切除的患者,化疗、局部治疗如消融、经动脉化疗和放射性栓塞,以及在非常晚期和转移性疾病中进行的外照射是可用的治疗选择。这些治疗方式可以提高总体无病生存和无进展生存的机会。在本综述中,我们将讨论肝内胆管癌的危险因素、临床表现、诊断、可用的治疗选择以及治疗选择的未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/8198953/34908d77d1c5/jcm-10-02368-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验